Pervin KARLI, Bahattin AVCI, Hatice KAYABAŞ, Fatma DEVRAN BILDIRCIN, Ayşe Zehra ÖZDEMİR, Tayfun ALPER

Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis

Aim: To determine the efficiency of serum amyloid-A (SAA) in predicting preterm premature rupture of membrane (PPROM) andchorioamnionitis in risky cases.Study Design: The study consists of 20 women 26-37 weeks of pregnancy who had PPROM and 20 pregnant women without waterbreaks. Levels of SAA were determined in maternal venous and umbilical cord blood.Results: SAA values in cord blood and venous blood of mothers with PPROM were higher than in the control group (p

PDF

___

1. Gabbe SG NJ, Simphson JL. Obstetrics;Normal and problem pregnancies. Third ed1996.
2. Alexander JM, Cox SM. Clinical course of premature rupture of the membranes. Semin Perinatol 1996;20:369-74.
3. Scott JR DJ, KHammond CB, Spellacy WN. Danforth’s Obstetrics Gynecol. Seventy edition 1994.
4. Duff P. Premature rupture of the membranes in term patients. Semin Perinatol 1996;20:401-8.
5. Ohlsson A. Treatments of preterm premature rupture of the membranes: a meta-analysis. Am J Obstet Gynecol 1989;160:890-906.
6. ACOG Committee on Practice Bulletins-Obstetrics a. Clinical management guidelines for obstetriciangynecologists. Obstetric Gynecology2007. p. 1007- 19.
7. Mercer BM, Goldenberg RL, Meis PJ, et al. The Preterm Prediction Study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2000;183:738- 45.
8. Joseph KS, Kramer MS, Marcoux S, et al. Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N Engl J Med 1998;339:1434-9.
9. Bengtson JM, VanMarter LJ, Barss VA, et al. Pregnancy outcome after premature rupture of the membranes at or before 26 weeks’ gestation. Obstet Gynecol 1989;73:921-7.
10. Dale PO, Tanbo T, Bendvold E, Moe N. Duration of the latency period in preterm premature rupture of the membranes. Maternal and neonatal consequences of expectant management. Eur J Obstet Gynecol Reprod Biol 1989;30:257-62.
11. Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003;101:178-93.
12. Mercer BM. Management of preterm premature rupture of the membranes. Clin Obstet Gynecol 1998;41:870-82.
13. Mercer BM. Antibiotic treatment for preterm premature rupture of membranes. Am J Obstet Gynecol 1996;175:755-6.
14. Parry S, Strauss JF, 3rd. Premature rupture of the fetal membranes. N Engl J Med 1998;338:663-70.
15. Harger JH, Hsing AW, Tuomala RE, et al. Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol 1990;163:130-7.
16. Asrat T, Garite TJ. Management of preterm premature rupture of membranes. Clin Obstet Gynecol 1991;34:730-41.
17. St Geme JW Jr, Murray DL, Carter J, et al. Perinatal bacterial infection after prolonged rupture of amniotic membranes: an analysis of risk and management. J Pediatr 1984;104:608-13.
18. Malle E, De Beer FC. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest 1996;26:427-35.
19. Husby G, Natvig JB. A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils. J Clin Invest 1974;53:1054-61.
20. Laurenti F FF, Campi E, Ceri E, et al. Originale significato delle proteine “maqqiari” della fase acuta. Aggiornamenti in neonatalogia, 1996;4:173-93.
21. Petrunin DD, Griaznova IM, Petrunina Iu A, et al. Immunochemical identification of organ specific human placental alphal-globulin and its concentration in amniotic fluid. Akush Ginekol (Mosk) 1977:62-4.
22. Lee SE, Park JS, Norwitz ER, et al. Measurement of placental alpha-microglobulin-1 in cervicovaginal discharge to diagnose rupture of membranes. Obstet Gynecol 2007;109:634-40.
23. Newton ER. Chorioamnionitis and intraamniotic infection. Clin Obstet Gynecol 1993;36:795-808.
24. van de Laar R, van der Ham DP, Oei SG, et al. Accuracy of C-reactive protein determination in predicting chorioamnionitis and neonatal infection in pregnant women with premature rupture of membranes: a systematic review. Eur J Obstet Gynecol Reprod Biol 2009;147:124-9.
25. de Villiers WJ, Louw JP, Strachan AF, et al. C-reactive protein and serum amyloid A protein in pregnancy and labour. Br J Obstet Gynaecol 1990;97:725-30.
26. Cicarelli LM, Perroni AG, Zugaib M, et al. Maternal and cord blood levels of serum amyloid A, C-reactive protein, tumor necrosis factor-alpha, interleukin1beta, and interleukin-8 during and after delivery. Mediators Inflamm 2005;2005:96-100.
27. Laurenti F SP, Capolupo I, Fioravanti S, et al. Studio della siero-proteina amiloide A nell’etu neonatale. Rivista Italiana Disease Pediatria 1996;22/5-2:1201.
28. Benson MD, Cohen AS. Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases. Arthritis Rheum 1979;22:36-42.